Dimebon in Alzheimer's disease: old drug for new indication
- 1 July 2008
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 372 (9634), 179-180
- https://doi.org/10.1016/s0140-6736(08)61046-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialThe Lancet Neurology, 2008
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled studyThe Lancet, 2008
- Minocycline Attenuates Neuronal Cell Death and Improves Cognitive Impairment in Alzheimer's Disease ModelsNeuropsychopharmacology, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trialNeurology, 2005
- The Development of Anti-Amyloid Therapy for Alzheimer???s DiseaseCNS Drugs, 2005
- Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trialThe Lancet, 1998